Literature DB >> 16232032

Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.

Michael A Shetzline1, Marielle Cohard-Radice, Bo Joelsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16232032     DOI： 10.1592/phco.2005.25.11.1684

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  2 in total

Review 1.  The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.

Authors:  James H Lewis
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

2.  Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom.

Authors:  Peter Layer; Jutta Keller; Helena Loeffler; Andreas Kreiss
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.